Skip to content

Effect of dexmedetomidine combined with ropivacaine in ultrasound-guided paravertebral nerve block for acute herpes zoster neuralgia patients

Effect of dexmedetomidine combined with ropivacaine in ultrasound-guided paravertebral nerve block for acute herpes zoster neuralgia patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058201
Enrollment
Unknown
Registered
2022-04-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

group 2:betamethasone

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients diagnosed with herpes zoster on the chest wall for the eruption less than 1 month; 2. Patients aged 50-80 years; 3. The patients were treated with antiviral therapy; 4. The patient's VAS score is 6 or more. 5. Obtain the consent of the patients and family members before the treatment, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with mild pain; 2. Puncture point infection or extensive skin lesions (no clean area for needle entry); 3. Patients were reported hepatic, renal, or pulmonary disease, diabetes and coagulopathy; 4. Patients who refused to participate.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) score;quality of sleep score;

Secondary

MeasureTime frame
Pregabalin consumption;complication;

Countries

China

Contacts

Public ContactYin Yanwei

The Affiliated Hospital of Qingdao University

yy5677@163.com+86 13963961956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026